Michael Shane Paladin, Chief Customer & Revenue Officer of Equinix Inc. (NASDAQ:EQIX), filed a Form 4 on September 3, 2026, disclosing the vesting of restricted stock units and the subsequent sale of shares on September 1 and 2, 2026.
Lucian Boldea, President and CEO of Timken Co, filed a Form 4 on September 3, 2026, reporting four transactions in Timken common stock on September 1, 2026, stemming from the vesting of restricted share units and associated tax withholding.
Director John Lovoi of Hornbeck Offshore Services, Inc. filed a Form 4 on September 3, 2026, reporting two transactions in the company's common stock occurring on September 1 and September 2, 2026.
Scott Andrew Sparks, Executive Vice President and Chief Operating Officer of Subsea Services and Well Intervention at Hornbeck Offshore Services, Inc., filed a Form 4 on September 3, 2026, disclosing changes in beneficial ownership connected to the completion of a merger between Helix Energy …
Kevin C. Gremer, Senior Executive Vice President, Chief Operations and Technology Officer of Fulton Financial Corp, filed a Form 4 on September 3, 2026, reporting the disposition of 803 shares of common stock on September 2, 2026.
A Form 4 filed on September 3, 2026 discloses that Randolph Altschuler, a director of Xometry, Inc. (NASDAQ:XMTR), reported the sale of Class A Common Stock on September 1, 2026, executed automatically under a Rule 10b5-1 trading plan adopted by his spouse.
Christian Kleinerman, Executive Vice President of Product Management at Snowflake Inc. (NYSE:SNOW), filed a Form 4 on September 3, 2026, disclosing the sale of 25,000 shares of common stock across two transactions dated September 1 and September 3, 2026.
Ruth Ann Marshall, a director of Conagra Brands Inc. (NYSE:CAG), filed a Form 4 on September 3, 2026, reporting the acquisition of 1,629.42 shares of common stock on September 1, 2026, in connection with deferred director's fees under the company's Directors' Deferred Compensation Plan.
Paul W. Breaux, Vice President, General Counsel, Secretary, and Chief Compliance Officer of Carvana Co., filed a Form 4 on September 3, 2026, disclosing the withholding of shares to cover taxes upon the vesting of restricted stock units.
Christopher R. Cline, Chief Financial Officer of Travere Therapeutics, Inc., filed a statement of changes in beneficial ownership on September 3, 2026, reporting a sale of 642 shares of common stock on September 2, 2026, to cover tax withholding obligations tied to vested restricted …